Notice ID: 7bca58e979a46fa136d76072c198cd53Special Notice
Tenwek Hospital In Kenya Esophageal Cancer Research (THINKER) Case-Control Study of Esophageal Squamous Cell Carcinoma in Western Kenya
Archived on August 8, 2019. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 5:00 PM UTC−05:00
- Posted
- July 10, 2019
- Notice type
- Special Notice
- NAICS
- 541380: Testing Laboratories and Services
Notice details
- PSC
- Q: MEDICAL SERVICES
- Last updated
- Dec 6, 2025
Identifiers
- Solicitation number
- 75N91019Q00097
- Notice ID
- 7bca58e979a46fa136d76072c198cd53
Description
Contracting Office Address Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E136, Bethesda, MD 20892, UNITED STATES Description The National Cancer Institute (NCI), Division of Cancer Epidemiology (DCEG), Metabolic Epidemiology Branch (MEB) plans to procure on a sole source basis, services to enroll 180 cases and 180 controls in the ongoing THINKER Case-Control Study of esophageal squamous cell carcinoma (ESCC). These activities are coordinated by the Contractor World Gospel Hospital; 3783 E State Road 18, Marion, IN, 46952-8768. This acquisition will be processed in accordance with the simplified acquisition procedures as authorized by FAR Part 13.106-1 (b) (1) and is exempt from the requirements of FAR Part 6. The North American Industry Classification System Code is 541380 and the business size standard is $15.0 million. Only one award will be made as a result of this solicitation. It has been determined there are no opportunities to acquire green products or services for this procurement. BACKGROUND Esophageal squamous cell carcinoma (ESCC) is common in the developing world, and it is a leading cancer diagnosis in Western Kenya. Tenwek Hospital is a 300-bed mission hospital located in Bomet, Kenya, approximately 200 miles northwest of Nairobi. Tenwek serves as a primary health care facility for approximately 400,000 people within a 50 km radius of the hospital, and it has become a referral center for a broader population. ESCC is the most common malignancy seen at Tenwek Hospital, and the patients show a very unusual age distribution, with about 8% of cases diagnosed at ? 30 years of age. The NCI's long-term goal is to understand the risk factors and pathogenesis of ESCC in Western Kenya, and to establish effective screening and prevention programs there. To accomplish these objectives, the NCI has designed and begun recruitment for a case-control study at Tenwek Hospital in Bomet, Kenya, where all research activities are coordinated by the Contractor. This case-control study, called the THINKER Study, is designed to recruit a total of 300 ESCC cases presenting to the hospital and 300 hospital in-patients who do not have ESCC as controls. Currently, 120 cases and 120 controls have been recruited and enrolled, funded by another mechanism, so the current procurement will pay for the recruitment of the remaining 180 cases and 180 controls. All subjects recruited will complete a risk factor questionnaire and provide saliva, blood, and urine samples. In addition, the 180 ESCC cases will undergo an endoscopy examination and biopsies of their esophagus. The final results of this study will describe risk factors for ESCC in this population, providing, for the first time, clues as to the etiology of ESCC in this population. On completion of the case-control study, an additional 180 ESCC cases will be invited to contribute a saliva sample and complete a brief (one page) questionnaire. These additional samples will contribute additional statistical power to a genome wide association study (GWAS) of ESCC in Africa. OBJECTIVE The objective of this procurement is to complete case and control enrollment in the THINKER Case-Control Study of ESCC at Tenwek Hospital in Bomet, Kenya (where research activities are coordinated by the Contractor). An additional 180 ESCC patients will also be invited to contribute a saliva sample and complete a brief (one page) questionnaire to contribute additional power to a GWAS study of ESCC in Africa. SCOPE The field team at Tenwek Hospital will enroll 180 ESCC cases and 180 controls using an mHealth platform which uploads enrollment and questionnaire data in real time. All participants will complete questionnaires about their demographics, usual diet, occupation, home and habits. In addition, both cases and controls will be asked to provide saliva, urine and blood samples, and cases will also provide a tumor biopsy and a biopsy of endoscopically normal-appearing mucosa. The samples will be processed, frozen onsite, and shipped to the NCI biorepository at the end of the study. An additional 180 ESCC patients will be invited to contribute a saliva sample and complete a brief (one page) questionnaire in order to contribute additional power to a genome wide association study of ESCC in Africa. CONTRACT REQUIREMENTS The Contractor shall: 1.1 Provide questionnaire information on 180 ESCC cases and 180 controls, recorded and uploaded in real time using the mHealth platform previously developed by the NCI and the Contractor; 1.2 Collect saliva, urine and blood samples from 180 ESCC cases and 180 controls, and tumor and normal tissue samples from 180 ESCC cases. The Contractor will process the samples immediately and freeze them on site, for delivery to the NCI biorepository at the end of the study; 1.3 Deliver a brief protocol outlining the plan and Standard Operating Procedures (SOPs) for the Case-Control study; and 1.4 Provide brief questionnaire information and a saliva sample from an additional 180 ESCC cases. TYPE OF ORDER This is a nonseverable Firm Fixed Price Purchase Order. The services specified in each contract line item (CLIN) have been determined to be nonseverable services - a specific undertaking or entire job with a defined end product of value to the Government. PERIOD OF PERFORMANCE The period of performance shall be 12 months from the purchase order award date. PLACE OF PERFORMANCE The place of performance will be Tenwek Hospital, Bomet, Kenya, whose research activities are coordinated and managed by the Contractor. REPORT(S)/DELIVERABLES AND DELIVERY SCHEDULE DELIVERABLE DELIVERABLE DESCRIPTION / FORMAT REQUIREMENTS DUE DATE #1 Protocol plan in Word or PDF format sent to NCI TPC 30 days after award #2 Complete questionnaire data as delivered via the mHealth platform previously developed by the NCI and the Contractor. 30 days after the enrollment of final case/control #3 360 saliva samples 360 urine samples 360 blood samples 180 esophageal tumor samples 180 normal esophageal tissue samples 30 days after the enrollment of final case/control #4 Brief questionnaire data from an additional 180 ESCC cases 30 days after the enrollment of final case #5 180 saliva samples from additional ESCC cases 30 days after the enrollment of final case Tenwek Hospital and the proposed Contractor World Gospel Mission, which coordinates and manages all research activities at Tenwek Hospital are uniquely qualified to undertake the completion of this case-control study of esophageal cancer, because they have already enrolled the first 120 cases and 120 controls of this study (funded through a previous subcontract), and the remaining 180 cases and 180 controls need to be enrolled using the same methods in the same population. Tenwek Hospital is situated within a high incidence region of esophageal squamous cell cancer and sees approximately 6 ESCC cases each week. Tenwek Hospital and the Contractor, the World Gospel Mission has built a highly trained research team who can consent, enroll, and interview patients, and take, process and store biospecimens. World Gospel Mission and Tenwek Hospital has worked with NCI to develop the mHealth platform that is used in this study, which allows real-time access (by NCI) to the study data. Based on the information above, World Gospel Mission is the only known Contractor to perform the services outlined in the Statement of Work. This notice is not a request for competitive quotation. However, if any interested party, especially small businesses, believes it can meet the above requirement, it may submit a capability statement, proposal, or quotation, which shall be considered by the agency. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. Responses must be received in the contracting office by 5:00 PM EST, on July 24, 2019. All responses and questions can be emailed to Kimesha Leake, Contracting Officer via electronic mail at kimesha.leake@nih.gov. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must be registered and have valid certification in the System for Award Management (SAM) through sam.gov. Reference: 75N91019Q00097 on all correspondence.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N91019Q00097- Special NoticeCurrentJul 10, 2019
Tenwek Hospital In Kenya Esophageal Cancer Research (THINKER) Case-Control Study of Esophageal Squamous Cell Carcinoma in Western Kenya
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
| - | Awarded | Open | |
Please, see attached Sources Sought Notice for full description as well as requested Capability Statement Submittals. This is a Sources Sought Notice for informational and market research purposes only. This Sources Sought does not constitute a Request for Quote, nor does it restrict the Government to an ultimate acquisition approach. This Sources Sought Notice should not be construed as a commitment by the Government for any purpose. Requests for a solicitation will not receive a response. This Sources Sought Notice is in support of market research being conducted by the St. Louis District, Corps of Engineers to identify interested and qualified contractors who can perform the type of work described in the attached Sources Sought Notice. USACE is not responsible for any costs incurred by interested parties in responding to this Sources Sought. | - | Market Research | 12/08/2026 |
Solicitation Extension | - | Solicitation | 11/20/2026 |
36C26227Q0022 ******* The purpose of this amendment is to: 1. Respond to questions asked regarding this solicitation. 2. Change the Period of Performance (POP) start date from 11/20/2026 to 12/01/2026. Base: 12/01/2026 09/30/2027 OY 1: 10/01/2027 09/30/2028 OY 2: 10/01/2028 09/30/2029 OY 3: 10/01/2029 09/30/2030 OY 4: 10/01/2030 09/30/2031 3. Change the response due date from 11/09/2026 to 11/12/2026. Questions and Answers: Q. Can you please let me know the total number of outlets to be tested. A. 3,000 Total. Q. # vacuum inlets A. 3,000 Q. # of medical gas system source equipment & location Bulk Oxygen, Med air, Vacuum, Nitrogen, WAGD, Dental Air, Dental Vacuum, Carbon Dioxide. Locations Main Hospital and Building 32 (cancer center) Q. # of medical gas booms/columns A. 38, Please see attachment named BOOM INVENTORY . Q. Could you please clarify whether the prime contractor must independently hold the ASSE 6020 Medical Gas Inspector and ASSE 6030 Medical Gas Verifier certifications, or whether these requirements can be satisfied through a qualified subcontractor whose personnel possess the required certifications? A. ASSE 6020 and ASSE 6030 certifications are required. Q. What are the manufacturer, model, and serial number of the boom equipment, source equipment, vacuum and air system? At a minimum, we need a manufacturer, model #, serial number for each system and each motor/compressor. Would providing photos of the source equipment be possible? A. We do not have the serial numbers or photos of the boom equipment but please see Exell spreadsheet attached Boom Inventory which has the Make, Model and location. Q. The Government provide the most recent annual medical gas inspection report, or an inventory showing quantities of outlets/inlets by gas type, zone valve boxes, area alarm panels, master alarm panels and source equipment? A. No, we cannot provide the inspection report but we are providing the boom inventory. Please see Exell spreadsheet attached Boom Inventory . Q. Can the Government provide the most recent annual medical gas inspection report, or an inventory showing quantities of outlets/inlets by gas type, zone valve boxes, area alarm panels, master alarm panels and source equipment? A. No Q. If this is a follow-on requirement, what is the prior contract number? A. Prior Contract No. : 36C26222C0020 Q. Which gases and systems are in scope (oxygen, medical air, vacuum, nitrous oxide, nitrogen, carbon dioxide, WAGD, instrument air)? A. Please refer to statement of work section V. Scope Q. Is the bulk oxygen tank owned and maintained by the gas supplier, with the contractor s scope limited to the pipeline side? A. The bulk oxygen is owned and maintained by the supplier. Q. Are Category 3 systems, such as dental air and vacuum, in scope? A. Yes Q. Does the Government expect only annual periodic inspection and testing, or a full NFPA 99 system verification each year? A. Only Annual. Q. Does each annual CLIN cover a single inspection event per year? A. Yes Q. May the ASSE 6020 and 6030 credentials be held by subcontractor personnel instead of the prime s employees? A. Certs. Must be held by the prime and subcontractor. Q. Must the field team include both a 6020 inspector and a 6030 verifier, or is credential acceptable for annual testing? A. Yes Q. Should pricing assume evening or weekend work for the ICU, OR, SICU and ED zones? A. Yes. Q. If a master alarm sensor is not on a demand check fitting, will the VA allow a brief isolation to test it, or is that test excluded? A. Yes, a brief moment. Q. Are photos required for every outlet/inlet, or only for sources, alarm panels, zone valves and deficiencies? A. Only deficiencies. Q. How many particulate and dewpoint sample points are expected, based on the number of floors in the Main Hospital and Buildings 30, 31 and 32? A. No. This test will only to be performed for installation, repair, or modification of any medical gas piping systems, Building 29, 30 has no medical gas. Q. When was the last annual inspection done, and when was the first inspection due under this contract? A. The last inspection was completed on 11/24/25 - 2026 inspection needs to be completed before 12/21/26. Q. Oxygen particulate analysis: This filter test is typically performed as a pre-test during construction projects under NFPA 99. The results would generally be expected to remain unchanged unless the pipeline is breached during construction. Please confirm whether this test is required as part of the annual inspection. A. No particulate test performed during verification of newly installed or modified medical gas piping systems only. Q. ASSE 6010 certification: Please confirm whether ASSE 6010 certification is required. Our understanding is that this is a medical gas installer certification, rather than an annual inspection requirement under NFPA 99. A. No, only if repairs need to be performed, contractor shall be 6010 certified to make repairs. Q. Boom testing frequency: Please confirm whether boom testing is required annually. Our understanding is that NFPA 99 recommends testing every 18 months. A. VA requires this test to be performed annually. Q. Boom testing scope: Please confirm whether the testing includes disassembly of the booms to inspect for leaks and dry rot. A. Yes Q. Boom testing report: Please confirm whether the detailed report should include photographs of disassembled booms and a comprehensive list of recommended repairs. A. Yes, if any deficiencies are found. Q. Building confirmation: Mr. Stockman indicated that Eye Clinic Building 32 and Audiology Building 30 should be excluded from the proposal. Please confirm. A. Only main Hospital and building 31 (cancer center) will be tested annually. Q. Could you please clarify what repair work, if any, must be included in the annual fixed price? Specifically, should the contractor include any routine repairs or corrective maintenance, or will all repairs, replacement parts, and installation services be treated as separately authorized work under Section VI? A. This solicitation is only for Inspection, not for repairs. In the Statement of Work (Section VII) we have to include "Over and Above Repair" to clarify that the contractor must notify the POC immediately if any repairs needs to be made. | - | Combined Synopsis | 11/12/2026 |
Provide the services of an ABS approved ESP Hull Gauging firm to take and record ultrasonic thickness readings on ship's hull, bulkheads, deck plating, scantlings, piping, and in other areas throughout the ship as required by the MSCREP, USCG, and ABS Surveyor. The requirements of the ABS Special Hull Survey No.8 for Single Hull Tankers in the Enhanced Survey Program shall form the basis for this item. See solicitation documents for additional details and submission requirements. | - | Combined Synopsis | 11/18/2026 |
Additional Details
Solicitation Number
75N91019Q00097
Archive Date
Aug 8, 2019